These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20531500)

  • 1. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent news in the treatment of lupus nephritis.
    Tesar V; Hruskova Z
    Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in the treatment of lupus nephritis.
    Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT
    Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
    Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose rituximab in refractory lupus nephritis.
    Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
    Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on the treatment of lupus nephritis.
    Bomback AS; Appel GB
    J Am Soc Nephrol; 2010 Dec; 21(12):2028-35. PubMed ID: 21051743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human clinical trials in lupus nephritis.
    Dooley MA; Falk RJ
    Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment strategies for proliferative lupus nephritis: keep children in mind!
    Ranchin B; Fargue S
    Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards new avenues in the management of lupus glomerulonephritis.
    Mok CC
    Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
    Suszek D; Wielosz E; Majdan M
    Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top 10 developments in lupus nephritis.
    Chen TK; Fine DM
    Curr Rheumatol Rep; 2013 Sep; 15(9):358. PubMed ID: 23893235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
    van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
    Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and future therapies for lupus nephritis.
    Appel GB
    Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
    Marks SD; Tullus K
    Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
    Rovin BH; Furie R; Latinis K; Looney RJ; Fervenza FC; Sanchez-Guerrero J; Maciuca R; Zhang D; Garg JP; Brunetta P; Appel G;
    Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.